ECDC/EMCDDA report: Evidence for the effectiveness of interventions to prevent infections among people who inject drugs. Part 1
Part 1: Needle and syringe programmes and other interventions for preventing hepatitis C, HIV and injecting risk behaviour
This is the first of two technical reports that present the evidence behind the Guidance on the prevention and control of infectious diseases among people who inject drugs.
The evidence presented here focuses on the effectiveness (and in some cases the cost-effectiveness) of the following interventions: the provision of needles and syringes; the provision of other (non-needle and syringe) drug preparation equipment; the provision of foil to stimulate route transition; the provision of information, education and counselling; knowledge of hepatitis C status; disease treatment; modes of service delivery including supervised injecting facilities; and access to, retention in, and combination of interventions.
Additional evidence on the effectiveness of drug treatment is covered in a companion technical report ‘Evidence for the effectiveness of interventions to prevent infections among people who inject drugs, Part 2: Drug treatment for preventing hepatitis C, HIV and injecting risk behaviour’.
Partial COVID-19 vaccination, vaccination following SARS-CoV-2 infection and heterologous vaccination schedule: summary of evidence
22 Jul 2021 - This document provides a review of evidence on three topics of interest (effectiveness of partial vaccination, immunogenicity and effectiveness of vaccination for previously infected individuals and safety and immunogenicity of heterologous schedules) to inform ongoing decision-making in relation to national vaccination policies and strategies in the European Union and European Economic Area (EU/EEA) countries.
COVID-19 in children and the role of school settings in transmission - second update
8 Jul 2021 - The aim of this document is to provide an update on the knowledge surrounding the role of children in the transmission of SARS-CoV-2 and the role of schools in the COVID-19 pandemic, focusing in particular on the experience in EU/EEA countries since the beginning of the pandemic. This document also addresses transmission to and from staff in school settings, school-related mitigation measures including risk communication, testing, contact tracing, and the effectiveness and impacts of school closures.
External quality assessment (EQA) schemes to support European surveillance of Legionnaires’ disease 2019−2020 - Western Balkans and Turkey
29 Jun 2021 - This is the first EQA exercise for laboratories participating in surveillance from the ELDSNet network that has been organised by ECDC since 2015 and the EQA format and arrangements have changed. The current EQA scheme uses an outbreak scenario with a package of clinical and environmental samples for the participating laboratories to process, depending on their technical capacity and protocols.